Reset filters

Search publications


Search by keyword
List by department / centre / faculty

No publications found.

 

A systematic review of existing peripheral biomarkers of cognitive aging: Is there enough evidence for biomarker proxies in behavioral modification interventions?: An initiative in association with the nutrition, exercise and lifestyle team of the Canadian Consortium on Neurodegeneration in Aging.

Authors: Fiocco AJKrieger LD'Amico DParrott MDLaurin DGaudreau PGreenwood CFerland G


Affiliations

1 Department of Psychology, Ryerson University, Toronto, ON, Canada. Electronic address: afiocco@psych.ryerson.ca.
2 Department of Psychology, Ryerson University, Toronto, ON, Canada.
3 Concordia University, Montreal, QC, Canada.
4 Laval University, Centre de recherche du CHU de Québec, QC, Canada.
5 Université de Montréal, Montréal, QC, Canada.
6 University of Toronto, Baycrest, Toronto, ON, Canada.

Description

A systematic review of existing peripheral biomarkers of cognitive aging: Is there enough evidence for biomarker proxies in behavioral modification interventions?: An initiative in association with the nutrition, exercise and lifestyle team of the Canadian Consortium on Neurodegeneration in Aging.

Ageing Res Rev. 2019 Jul;52:72-119

Authors: Fiocco AJ, Krieger L, D'Amico D, Parrott MD, Laurin D, Gaudreau P, Greenwood C, Ferland G

Abstract

Peripheral biomarkers have shown significant value in predicting brain health and may serve as a useful proxy measurement in the assessment of evidence-based lifestyle behavior modification programs, including physical activity and nutrition programs, that aim to maintain cognitive function in late life. The aim of this systematic review was to elucidate which peripheral biomarkers are robustly associated with cognitive function among relatively healthy non-demented older adults. Following the standards for systematic reviews (PICO, PRIMSA), and employing MEDLINE and Scopus search engines, 222 articles were included in the review. Based on the review of biomarker proxies of cognitive health, it is recommended that a comprehensive biomarker panel, or biomarker signature, be developed as a clinical end point for behavior modification trials aimed at enhancing cognitive function in late life. The biomarker signature should take a multisystemic approach, including lipid, immune/inflammatory, and metabolic biomarkers in the biological signature index of cognitive health.

PMID: 31059801 [PubMed - in process]


Links

PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31059801?dopt=Abstract